{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T11:44:43Z","timestamp":1774698283342,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jtho.2017.05.023","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T03:02:35Z","timestamp":1497582155000},"page":"1434-1441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Resectable Clinical N2 Non\u2013Small Cell Lung Cancer; What Is the Optimal Treatment Strategy? An Update by the British Thoracic Society Lung Cancer Specialist Advisory Group"],"prefix":"10.1016","volume":"12","author":[{"given":"Matthew","family":"Evison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Clive","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianne","family":"Castle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Buttery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidan","family":"Masani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Harden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doug","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Woolhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2017.05.023_bib1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/JTO.0b013e31812f3c1a","article-title":"The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours","volume":"2","author":"Goldstraw","year":"2007","journal-title":"J\u00a0Thorac Oncol"},{"issue":"suppl 5","key":"10.1016\/j.jtho.2017.05.023_bib2","doi-asserted-by":"crossref","first-page":"e314S","DOI":"10.1378\/chest.12-2360","article-title":"Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Ramnath","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jtho.2017.05.023_bib3","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/annonc\/mdv187","article-title":"2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer","volume":"26","author":"Eberhardt","year":"2015","journal-title":"Ann Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.jtho.2017.05.023_bib4","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1136\/thx.2010.145938","article-title":"Guidelines on the radical management of patients with lung cancer","volume":"65","author":"Lim","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.jtho.2017.05.023_bib5","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/jnci\/djk093","article-title":"Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer","volume":"99","author":"van Meerbeeck","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.jtho.2017.05.023_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0360-3016(02)02943-7","volume":"54","author":"Johnstone","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.jtho.2017.05.023_bib7","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/thoraxjnl-2014-206292","article-title":"Outcome of surgery versus radiotherapy after induction treatment in patients with N2 disease: systematic review and meta-analysis of randomised trials","volume":"70","author":"McElnay","year":"2015","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.jtho.2017.05.023_bib8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/bjc.1998.560","article-title":"Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group Study","volume":"78","author":"Shepherd","year":"1998","journal-title":"Br\u00a0J Cancer"},{"key":"10.1016\/j.jtho.2017.05.023_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.lungcan.2005.04.001","article-title":"Medical Research Council Lung Cancer Working P. A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer","volume":"49","author":"Stephens","year":"2005","journal-title":"Lung Cancer"},{"issue":"35","key":"10.1016\/j.jtho.2017.05.023_bib10","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1200\/JCO.2015.62.6812","article-title":"Phase III study\u00a0of surgery versus definitive concurrent chemoradiotherapy boost in patients with resectable stage IIIA(N2) and selected IIIB non-small-cell lung cancer after\u00a0induction chemotherapy and concurrent chemoradiotherapy (ESPATUE)","volume":"33","author":"Eberhardt","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2017.05.023_bib11","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(15)60294-X","article-title":"Induction chemoradiation in stage IIIA\/N2 non-small-cell lung cancer: a phase 3 randomised trial","volume":"386","author":"Pless","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jtho.2017.05.023_bib12","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1002\/cncr.26689","article-title":"A\u00a0phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903)","volume":"118","author":"Katakami","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jtho.2017.05.023_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0140-6736(09)60737-6","article-title":"Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial","volume":"374","author":"Albain","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jtho.2017.05.023_bib14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S1470-2045(08)70156-6","article-title":"Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer","volume":"9","author":"Thomas","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2017.05.023_bib15","unstructured":"Rosell et\u00a0al. 1999."},{"key":"10.1016\/j.jtho.2017.05.023_bib16","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1200\/jco.2005.23.16_suppl.7146","article-title":"Scandinavian phase III trial of neoadjuvant chemotherapy in NSCLC stages IB-IIIA\/T3","volume":"23","author":"Sorensen","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2017.05.023_bib17","doi-asserted-by":"crossref","first-page":"e879","DOI":"10.1097\/MD.0000000000000879","article-title":"Is there a survival benefit in patients with stage IIIA (N2) non-small cell lung cancer receiving neoadjuvant chemotherapy and\/or radiotherapy prior to surgical resection: a systematic review and meta-analysis","volume":"94","author":"Xu YP LB","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.jtho.2017.05.023_bib18","first-page":"845","article-title":"Neoadjuvant chemoradiotherapy or chemotherapy followed by surgery is superior to that followed by definitive chemoradiation or radiotherapy in stage 111A (N2) nonsmall-cell lung cancer: a meta-analysis and system review","volume":"9","author":"Xu","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jtho.2017.05.023_bib19","first-page":"1414","article-title":"Randomized controlled trials of induction treatment and surgery versus combined chemotherapy and radiotherapy in stages IIIA-N2 NSCLC: a systematic review and meta-analysis","volume":"7","author":"Ren","year":"2015","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jtho.2017.05.023_bib20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/ejcts\/ezu028","article-title":"Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer","volume":"45","author":"De Leyn","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2017.05.023_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/JTO.0b013e31807ec803","article-title":"The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer","volume":"2","author":"Rusch","year":"2007","journal-title":"J\u00a0Thorac Oncol"}],"updated-by":[{"DOI":"10.1016\/j.jtho.2018.11.015","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000}}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086417304483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086417304483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T21:53:10Z","timestamp":1535752390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086417304483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1556086417304483"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2017.05.023","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jtho.2018.11.015","asserted-by":"object"}]},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resectable Clinical N2 Non\u2013Small Cell Lung Cancer; What Is the Optimal Treatment Strategy? An Update by the British Thoracic Society Lung Cancer Specialist Advisory Group","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2017.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier Inc. on behalf of International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}]}}